- Clindamycin Hydrochloride Capsules
- SFDA Approval No.：H32020588
- Dosage Form：Capsules
- Indication：To treat following infections caused by streptococcus, staphylococcus, anaerobe and other sensitive strains: tympanitis, nasosinusitis, suppurative tonsillitis, pneumonia, skin and soft tissue infections. And it can be used separately or
Generic Name：Clindamycin Hydrochloride Capsules
Chinese Phonetic Alphabet: Yansuan Kelinmeisu Jiaonang
【Indications】It is suitable for the following infections caused by sensitive strains such as Streptococcus, Staphylococcus and Anaerobic bacteria: otitis media, sinusitis, suppurative tonsillitis, pneumonia; skin and soft tissue infections; treatment of bone and joint infections, abdominal infections , pelvic infection, empyema, lung abscess, osteomyelitis, sepsis, etc., may be used alone or in combination with other antibacterial agents.
【Specification】0.15g by C18H33ClN2O5S
【Package】Pharmaceutical PVC hard sheet and PTP aluminum foil for drug package. 10 capsules /plate×1 plate/box；12 capsules /plate×1 plate/box.
【In case there is any discrepancy between the Chinese version and the English version, the Chinese version shall prevail.】